For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
The Global Info Research report includes an overview of the development of the Targeted RNA Sequencing industry chain, the market status of Research Institutes (Exome Sequencing, Enrichment Sequencing), Hospitals & Clinics (Exome Sequencing, Enrichment Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted RNA Sequencing.
Regionally, the report analyzes the Targeted RNA Sequencing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted RNA Sequencing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Targeted RNA Sequencing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted RNA Sequencing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Exome Sequencing, Enrichment Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted RNA Sequencing market.
Regional Analysis: The report involves examining the Targeted RNA Sequencing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted RNA Sequencing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Targeted RNA Sequencing:
Company Analysis: Report covers individual Targeted RNA Sequencing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted RNA Sequencing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research Institutes, Hospitals & Clinics).
Technology Analysis: Report covers specific technologies relevant to Targeted RNA Sequencing. It assesses the current state, advancements, and potential future developments in Targeted RNA Sequencing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted RNA Sequencing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Targeted RNA Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Exome Sequencing
- Enrichment Sequencing
- Amplicon Sequencing
Market segment by Application
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
Market segment by players, this report covers
- Thermo Fisher
- Illumina
- Roche Holdings
- BGI
- Eurofins
- LabCorp
- Berry Genomics
- Macrogen
- GENEWIZ
Market segment by regions, regional analysis covers
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted RNA Sequencing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted RNA Sequencing, with revenue, gross margin and global market share of Targeted RNA Sequencing from 2019 to 2024.
Chapter 3, the Targeted RNA Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Targeted RNA Sequencing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted RNA Sequencing.
Chapter 13, to describe Targeted RNA Sequencing research findings and conclusion.